{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:10:15Z","timestamp":1782997815383,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005703","name":"Akdeniz University","doi-asserted-by":"publisher","award":["2012.02.0122.015"],"award-info":[{"award-number":["2012.02.0122.015"]}],"id":[{"id":"10.13039\/501100005703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.nmd.2016.10.012","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T13:15:21Z","timestamp":1478265321000},"page":"128-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis"],"prefix":"10.1016","volume":"27","author":[{"given":"Irem","family":"Kanatli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahter Dilsad","family":"Sanlioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2016.10.012_bib0010","first-page":"897","article-title":"Myasthenia gravis","volume":"52","author":"Khadilkar","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.nmd.2016.10.012_bib0015","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2016.10.012_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0960-5428(94)00040-U","article-title":"The role of the thymus in myasthenia gravis","volume":"4","author":"Hohlfeld","year":"1994","journal-title":"Adv Neuroimmunol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00595-009-4134-2","article-title":"Biological implications of thymectomy for myasthenia gravis","volume":"40","author":"Okumura","year":"2010","journal-title":"Surg Today"},{"key":"10.1016\/j.nmd.2016.10.012_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1052-3359(25)00569-1","article-title":"Imaging of the thymus","volume":"11","author":"Mendelson","year":"2001","journal-title":"Chest Surg Clin N Am"},{"key":"10.1016\/j.nmd.2016.10.012_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.10.012_bib0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/A:1011336726649","article-title":"The potential of TRAIL for cancer chemotherapy","volume":"6","author":"Nagane","year":"2001","journal-title":"Apoptosis"},{"key":"10.1016\/j.nmd.2016.10.012_bib0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0952-7915(98)80224-0","article-title":"TRAIL: a molecule with multiple receptors and control mechanisms","volume":"10","author":"Griffith","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2004.02.006","article-title":"Targeting death receptors in cancer with Apo2L\/TRAIL","volume":"4","author":"Kelley","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tem.2013.07.001","article-title":"On the TRAIL of obesity and diabetes","volume":"24","author":"Harith","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.nmd.2016.10.012_bib0060","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1593\/neo.03421","article-title":"Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand","volume":"6","author":"Secchiero","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.nmd.2016.10.012_bib0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni894","article-title":"Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-\/- mice","volume":"4","author":"Lamhamedi-Cherradi","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0070","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bcp.2004.04.026","article-title":"Nuclear factor-kappaB: a friend or a foe in cancer?","volume":"68","author":"Shishodia","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/intimm\/dxm144","article-title":"No requirement for TRAIL in intrathymic negative selection","volume":"20","author":"Cretney","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20050471","article-title":"Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels","volume":"202","author":"Derbinski","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.nmd.2016.10.012_bib0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","article-title":"Apo2L\/TRAIL and its death and decoy receptors","volume":"10","author":"LeBlanc","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.nmd.2016.10.012_bib0100","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/01.CIR.0000062702.60708.C4","article-title":"TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways","volume":"107","author":"Secchiero","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2016.10.012_bib0105","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.2337\/diabetes.52.9.2274","article-title":"Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes","volume":"52","author":"Lamhamedi-Cherradi","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.nmd.2016.10.012_bib0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20030634","article-title":"Normal thymocyte negative selection in TRAIL-deficient mice","volume":"198","author":"Cretney","year":"2003","journal-title":"J Exp Med"},{"issue":"Suppl. 2","key":"10.1016\/j.nmd.2016.10.012_bib0115","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1038\/sj.cdd.4401525","article-title":"TRAIL and thymocyte apoptosis: not so deadly?","volume":"11","author":"Corazza","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.nmd.2016.10.012_bib0120","first-page":"847","article-title":"Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo","volume":"60","author":"Nagane","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.nmd.2016.10.012_bib0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.cgt.7700877","article-title":"Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis","volume":"13","author":"Sanlioglu","year":"2006","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.nmd.2016.10.012_bib0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2407-5-54","article-title":"Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells","volume":"5","author":"Sanlioglu","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nmd.2016.10.012_bib0135","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.cgt.7701087","article-title":"DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells","volume":"14","author":"Sanlioglu","year":"2007","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.nmd.2016.10.012_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/hum.2006.111","article-title":"Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells","volume":"18","author":"Aydin","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nmd.2016.10.012_bib0145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/1471-2407-10-584","article-title":"NF-kappaB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL","volume":"10","author":"Aydin","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nmd.2016.10.012_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2016.10.012_bib0155","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/MCB.21.12.3964-3973.2001","article-title":"NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling","volume":"21","author":"Kreuz","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/35070096","article-title":"Regulation of death receptor expression and TRAIL\/Apo2L-induced apoptosis by NF-kappaB","volume":"3","author":"Ravi","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0165","doi-asserted-by":"crossref","first-page":"G1357","DOI":"10.1152\/ajpgi.2001.281.6.G1357","article-title":"Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation","volume":"281","author":"Hatano","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.nmd.2016.10.012_bib0170","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V99.11.4079","article-title":"Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.nmd.2016.10.012_bib0175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/1471-2407-10-348","article-title":"Myc suppression of Nfkb2 accelerates lymphomagenesis","volume":"10","author":"Keller","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nmd.2016.10.012_bib0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1475-2867-13-56","article-title":"Determination of the apoptotic index in osteosarcoma tissue and its relationship with patients prognosis","volume":"13","author":"Wu","year":"2013","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.nmd.2016.10.012_bib0185","series-title":"The thymus gland","author":"Anastasiadis","year":"2007"},{"key":"10.1016\/j.nmd.2016.10.012_bib0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1172\/JCI39395","article-title":"The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease","volume":"120","author":"Na","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2016.10.012_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2016.10.012_bib0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2016.10.012_bib0205","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/157488709787047530","article-title":"TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges","volume":"4","author":"Bellail","year":"2009","journal-title":"Rev Recent Clin Trials"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616301717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616301717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:45Z","timestamp":1760774685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616301717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0960896616301717"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.10.012","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}